Clinical Trial Update: OssDsign® Spine Registry Study ("Propel")

View source ↗

Summary

OssDsign reports that its Spine Registry Study (Propel) is currently recruiting, aiming to collect outcome data for patients with degenerative disc disease and …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Degenerative Disc Disease
• Spinal Stenosis

Snippet

Sponsor: OssDsign | Conditions: Degenerative Disc Disease, Spinal Stenosis | Status: RECRUITING